--- the subscriber area has no ads and those above are not selected or endorsed by this site ---


Wednesday presentations & more ?2


Lots is happening in the real world with vaccines starting to be administered in America and Canada, and another on the way.  There's still nothing definitive on Brexit or a relief package from Congress, though the latter looks a bit more hopeful.  Elsewhere, there is progress as planned with CTY redemption, Huawei gear replacement, and threats from every possible angle to Google and other big tech companies.  The antitrust measures are likely to eventually make a substantial mark, but if you thought any of this was going to make an immediate splash in the market, though, then you haven't been reading or looking at €/$1.215.

Vuzix plans to give a presentation on the use of its technology in the healthcare on industry on Wednesday at noon.  Since I expect the market-moving news flow to continue to be slow, and Vuzix appears have a chance avoiding further dilution, I'll give the presentation on this use case some attention once I'm done with Nokia earlier that morning.  Hopefully it will offer more of an update than today's presentation from Resonant, but I still don't see either stock as attractively priced right now.